Disgraced Italian surgeon convicted of criminal harm to stem cell patient
By Gretchen Vogel,
Science
| 06. 16. 2022
Photo by Piron Guillaume on Unsplash
A surgeon who just a decade ago was celebrated around the globe as a pioneer in stem cell transplants has been convicted of one count of “causing bodily harm,” a felony, in a Swedish court. The district court in Solna today found Paolo Macchiarini not guilty on other charges, including aggravated assault, relating to three patients he treated while working for the famed Karolinska Institute (KI). The court said the penalty was “a suspended sentence,” but did not specify how long the sentence would be if imposed. The maximum prison sentence for causing bodily harm is 4 years.
The verdict is the latest development in Macchiarini’s stunning fall from grace. In 2010, the Italian surgeon was recruited by KI—home of the committee that awards the Nobel Prize in Physiology or Medicine. A year later, he began to implant synthetic windpipes seeded with stem cells isolated from the patients’ own bone marrow, claiming the cells would grow and integrate with the patients’ tissue. The operations were hailed at the timeas a breakthrough in regenerative...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...